Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (11-20 of 515) with videos related to

Pageof 52
Sort By:
Current Hematologic Malignancy Reports|April 29, 2010
Role of allogeneic stem cell transplantation in multiple myelomaShaji Kumar
Current Opinion in Oncology|June 18, 2009
Stem cell transplantation for multiple myelomaShaji Kumar
Blood|January 31, 2015
Blind men and an elephantShaji Kumar
Current Hematologic Malignancy Reports|April 29, 2010
Role of autologous stem cell transplantation in multiple myelomaShaji Kumar
Current Hematologic Malignancy Reports|March 12, 2011
Treatment of newly diagnosed multiple myeloma in transplant-eligible patientsShaji Kumar
Haematologica|September 29, 2022
One disease, many facesShaji Kumar
The Lancet. Haematology|April 1, 2016
Post-transplant therapy in multiple myeloma: a hung jury?Shaji Kumar
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis Due to Clonal Plasma Cell DiseasesGiada Bianchi, Shaji Kumar
Oncology (Williston Park, N.Y.)|September 5, 2014
Current advances in non-proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaAbhishek Singla, Shaji Kumar
Cancer Treatment and Research|October 4, 2016
Management of Transplant-Eligible Patients with Newly Diagnosed Multiple MyelomaJacob Laubach, Shaji Kumar
Pageof 52

Showing results (11-20 of 515) with videos related to

Sort By:
Pageof 52
Current Hematologic Malignancy Reports|April 29, 2010
Role of allogeneic stem cell transplantation in multiple myelomaShaji Kumar
Current Opinion in Oncology|June 18, 2009
Stem cell transplantation for multiple myelomaShaji Kumar
Blood|January 31, 2015
Blind men and an elephantShaji Kumar
Current Hematologic Malignancy Reports|April 29, 2010
Role of autologous stem cell transplantation in multiple myelomaShaji Kumar
Current Hematologic Malignancy Reports|March 12, 2011
Treatment of newly diagnosed multiple myeloma in transplant-eligible patientsShaji Kumar
Haematologica|September 29, 2022
One disease, many facesShaji Kumar
The Lancet. Haematology|April 1, 2016
Post-transplant therapy in multiple myeloma: a hung jury?Shaji Kumar
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis Due to Clonal Plasma Cell DiseasesGiada Bianchi, Shaji Kumar
Oncology (Williston Park, N.Y.)|September 5, 2014
Current advances in non-proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaAbhishek Singla, Shaji Kumar
Cancer Treatment and Research|October 4, 2016
Management of Transplant-Eligible Patients with Newly Diagnosed Multiple MyelomaJacob Laubach, Shaji Kumar
Pageof 52